Diverse Models for the Prediction of Dual mTOR and PI3K Inhibitory Activities of Substituted 4-morpholinopyrrolopyrimidines

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 4, 2014-05 ,pp. : 454-473

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Recombinant Fusion Protein Exhibited Inhibitory Activities on Platelet Aggregation and Thrombin

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 3, 2010-03 ,pp. : 182-187

Bentham Science Publishers

Access to resources Recommend Favorite

Peginterferon-α_2a (40 kDa) for chronic hepatitis C

By Hadziyannis Stephanos J   Papatheodoridis George V  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 541-551

Informa Healthcare

Access to resources Recommend Favorite

Modulation of a 40-kDa catecholamine regulated protein by dopamine receptor antagonists

By Sharan N.   Nair  

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Modulation of a 40-kDa catecholamine-regulated protein following d-amphetamine treatment in discrete brain regions

By Gabriele J.   Rajaram M.   Zhang B.   Sharma S.   Mishra R.K.  

European Journal of Pharmacology, Vol. 453, Iss. 1, 2002-10 ,pp. : 13-19

Elsevier

Access to resources Recommend Favorite